HHLA2 was significantly elevated in BUC and significantly correlated with cancer size, stage, grade, and the presence of lymph node metastasis; HHLA2 can be used independently to predict BUC prognosis [163]. Here, HHLA2 is linked to metastatic malignant neoplasm in the lymph nodes.